HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. The Company specializes in novel therapeutics to treat chronic and high-prevalence retinal diseases. Kodiak Sciences serves customers in the Unites States.
| Q4 2018 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade KOD now: | |
|
| Filers who had this stock in their top 10: | 1 | 0 (0.0%) |
| 13F Filers holding this stock: | 34 | 5 (0.5%) |
| Aggregate 13F shares on 12/31/2018: | 17.598 Million | 14.517 Million |
| Aggregate 13F shares on 09/30/2018: | 0 | |
| Percent change: | ||
| Funds creating new positions: | 33 | 5 |
| Funds Adding to an existing position: | ||
| Funds closing out their position: | ||
| Funds reducing their position: | ||
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
View recent insider trading info
Kodiak Sciences Inc Chart by YCharts
Please sign in first
none
none
80 Thousand total shares from 1 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
LIANG HONG SEE REMARKS |
|
100,000 | 2019-02-07 | 1 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-02-07 | M | 80,000 | $1.04 | a | 100,000 | 100,000.00 | direct | ||
| 2019-02-07 | M | 80,000 | d | 32,000 | 100,000.00 | direct |
